These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29599390)

  • 1. Use of neuropsychological tests for the diagnosis of dementia: a survey of Italian memory clinics.
    Di Pucchio A; Vanacore N; Marzolini F; Lacorte E; Di Fiandra T; ; Gasparini M
    BMJ Open; 2018 Mar; 8(3):e017847. PubMed ID: 29599390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A National Survey of Centers for Cognitive Disorders and Dementias in Italy.
    Canevelli M; Di Pucchio A; Marzolini F; Mayer F; Massari M; Salvi E; Palazzesi I; Lacorte E; Bacigalupo I; Di Fiandra T; Vanacore N
    J Alzheimers Dis; 2021; 83(4):1849-1857. PubMed ID: 34459403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for frontotemporal dementias and Alzheimer's disease with the Philadelphia Brief Assessment of Cognition: a preliminary analysis.
    Libon DJ; Massimo L; Moore P; Coslett HB; Chatterjee A; Aguirre GK; Rice A; Vesely L; Grossman M
    Dement Geriatr Cogn Disord; 2007; 24(6):441-7. PubMed ID: 17971665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI).
    Limongi F; Noale M; Bianchetti A; Ferrara N; Padovani A; Scarpini E; Trabucchi M; Maggi S;
    Aging Clin Exp Res; 2019 Jan; 31(1):101-107. PubMed ID: 30178442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction.
    Perri R; Koch G; Carlesimo GA; Serra L; Fadda L; Pasqualetti P; Pettenati C; Caltagirone C
    J Neurol; 2005 Oct; 252(10):1238-44. PubMed ID: 15906058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia.
    Metzler-Baddeley C
    Cortex; 2007 Jul; 43(5):583-600. PubMed ID: 17715794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.
    Oh SI; Park A; Kim HJ; Oh KW; Choi H; Kwon MJ; Ki CS; Kim HT; Kim SH
    PLoS One; 2014; 9(2):e87163. PubMed ID: 24498297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice.
    Rozzini L; Ceraso A; Zanetti M; Pelizzari S; Tomasoni E; Accardo V; Padovani A
    Behav Neurol; 2017; 2017():3781407. PubMed ID: 29147068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does additional diagnostic testing influence the initial diagnosis in patients with cognitive complaints in a memory clinic setting?
    Meijs AP; Claassen JA; Rikkert MG; Schalk BW; Meulenbroek O; Kessels RP; Melis RJ
    Age Ageing; 2015 Jan; 44(1):72-7. PubMed ID: 24847028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel technology to screen for cognitive impairment in the elderly.
    Wright DW; Nevárez H; Kilgo P; LaPlaca M; Robinson A; Fowler S; Brumfield J; Goldstein FC
    Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):484-91. PubMed ID: 22110158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
    Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
    Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias.
    Davis DH; Creavin ST; Yip JL; Noel-Storr AH; Brayne C; Cullum S
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010775. PubMed ID: 26513331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.
    Chan CC; Fage BA; Burton JK; Smailagic N; Gill SS; Herrmann N; Nikolaou V; Quinn TJ; Noel-Storr AH; Seitz DP
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011414. PubMed ID: 31521064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.
    Kramer JH; Jurik J; Sha SJ; Rankin KP; Rosen HJ; Johnson JK; Miller BL
    Cogn Behav Neurol; 2003 Dec; 16(4):211-8. PubMed ID: 14665820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a European Cross-Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia.
    Nielsen TR; Segers K; Vanderaspoilden V; Beinhoff U; Minthon L; Pissiota A; Bekkhus-Wetterberg P; Bjørkløf GH; Tsolaki M; Gkioka M; Waldemar G
    Int J Geriatr Psychiatry; 2019 Jan; 34(1):144-152. PubMed ID: 30246268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.